Life sciences briefing: Friday, Jan. 25, 2008
TODAY’S HEADLINES:
Health-info site HealthCentral Network pulls in $50M (paidContent)
BrightHeart Vet corrals $29M to acquire animal hospitals (release)
AviaraDx raises $8M for cancer diagnostics (peHUB)
Valor Medical aims for $15M for brain-aneurysm treatment (VentureWire)
IPC, inpatient-care provider, raises as much as $56M in IPO (IPO Home)
Phenomix, diabetes and hepatitis drug maker, files for $86M IPO (Edgar)
TVM Capital promotes Keiarasch “Kia” Parssanedjad to principal in life sciences (release)
BrightHeart Vet corrals $29M to acquire animal hospitals — BrightHeart Veterinary Centers, an… Continue Reading
Life sciences briefing: Wednesday, Dec. 26, 2007
TODAY’S HEADLINES:
Romark Labs raises $18M for hepatitis drugs (release)
Cubist buys Illumigen Bio, a hepatitis-drug biotech, for $9M (release)
MedCap voices opposition to VaxGen-Raven Bio reverse merger (release)
NeuroMetrix acquires EyeTel Imaging assets for $10M (release)
Solstice Neurosciences appoints Dennis Smith as CEO (release)
LeMaitre Vascular snaps up graft maker Biomateriali for €4M (release)
Bosch Group acquires remote health-monitoring co. Health Hero Network (release)
Romark Labs raises $18M for hepatitis drugs – Tampa, Fla.-based Romark Laboratories, a biotech developing drugs for hepatitis and… Continue Reading
Life sciences briefing: Wednesday, Sept. 26, 2007
Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media
UPDATED at 5:45am on 9/27/07
GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new forms of immunotherapy to treat viral infections and cancer, raised $41.2 million in a third funding round. Investors included Wexford Capital, Celgene, the Mellon Family Investment Company, the Richard King Mellon Foundation, Eminent Venture Capital, Boston Life Science Venture, WRF Capital, HealthCare Ventures,… Continue Reading